The Exchange of Scientific Information During COVID-19, Part 2: Content

By Mark Schoeman One of Clear Point Health’s core lines of busin­­­ess is engaging key opinion leaders (KOLs) on behalf of pharmaceutical companies, to glean their insights on a variety of subjects. One of the most important areas of our research centers on optimizing relationships between KOLs and those who serve as their primary contacts …

The Exchange of Scientific Information During COVID-19, Part 2: Content Read More »